Showing results (461-470 of 6,286) with videos related to

Sort By:
Pageof 629
Diabetes, Obesity & Metabolism|August 3, 2019
Evaluation of weight change and hypoglycaemia as mediators in the association between insulin use and deathJea Young Min, Amber J Hackstadt, Marie R Griffin, et al.
Diabetes, Obesity & Metabolism|May 15, 2015
Biosimilar insulins: guidance for data interpretation by clinicians and usersL Heinemann, P D Home, M Hompesch
Diabetes, Obesity & Metabolism|April 30, 2015
Inhibiting or antagonizing glucagon: making progress in diabetes careP J Lefèbvre, N Paquot, A J Scheen
Diabetes, Obesity & Metabolism|May 2, 2015
Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetesR Ritzel, R Roussel, G B Bolli, et al.
Diabetes, Obesity & Metabolism|May 2, 2015
Similar efficacy and safety of LY2963016 insulin glargine and insulin glargine (Lantus®) in patients with type 2 diabetes who were insulin-naïve or previously treated with insulin glargine: a randomized, double-blind controlled trial (the ELEMENT 2 study)J Rosenstock, P Hollander, A Bhargava, et al.
Diabetes, Obesity & Metabolism|August 27, 2025
Impact of glucagon-like peptide-1 receptor agonists on the incidence of inflammatory bowel disease in people with type 2 diabetesFu-Shun Yen, Shiow-Ing Wang, Yao-Min Hung, et al.
Diabetes, Obesity & Metabolism|July 25, 2016
Biliary effects of liraglutide and sitagliptin, a 12-week randomized placebo-controlled trial in type 2 diabetes patientsMark M Smits, Lennart Tonneijck, Marcel H A Muskiet, et al.
Diabetes, Obesity & Metabolism|August 28, 2025
Disrupted specialist outpatient services and alternative modes of service for patients with diabetes mellitus: A population-based, retrospective cohort study in Hong KongYuk Kam Yau, Meijiao Li, Jianchao Quan, et al.
Diabetes, Obesity & Metabolism|August 28, 2025
Glycaemic control after connected insulin pen initiation in people living with diabetes: Results from a real-world settingPeter Adolfsson, Bruno Guerci, Niels Væver Hartvig, et al.
Diabetes, Obesity & Metabolism|September 1, 2025
Proteomics-enabled learning machine algorithms enhance the prediction of cardiovascular diseases in patients with type 2 diabetes mellitusBowei Yu, Jiang Li, Yuefeng Yu, et al.
Pageof 629